Gilead Sciences, Inc. - 10%+ Owner at Kyverna Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
KYTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Gilead Sciences, Inc. since 11/5/2023

Holdings reported by Gilead Sciences, Inc. for Kyverna Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4.13M Feb 12, 2024 Direct
Series A-2 Convertible Preferred Stock 0 Feb 12, 2024 Direct Common Stock
Series B Convertible Preferred Stock 0 Feb 12, 2024 Direct Common Stock

Transactions reported by Gilead Sciences, Inc. for Kyverna Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.